Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate
- Development stage
- Unknown
- Modality
- Small Molecules, Peptides
01
Overview
Methyl N-{[(1R)-1-( { 1-[ (benzyloxy ) carbon yl ] -L-prolyl -6-ammonio -L-norleuc yl } amino ) – 2 – phenyleth yl ] ( hydro xy ) phosph ory l } – L-alanyl – L-prolin ate is a synthetic peptide-based small molecule, primarily studied as an experimental compound. It is not approved for clinical use and has no known marketed indications. The compound features a complex structure with multiple amino acid residues and a phosphorylated moiety, suggesting it may have been designed as an enzyme inhibitor or for biochemical research purposes. Its mechanism of action, pharmacological targets, and therapeutic applications are not established in the literature[2][3][7].
- Other names
- Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome((5S)-6-(((1R)-1-(hydroxy-(((2S)-1-((2S)-2-methoxycarbonylpyrrolidin-1-yl)-1-oxopropan-2-yl)amino)phosphoryl)-2-phenylethyl)amino)-6-oxo–5–(((2S)–1–phenylmethoxycarbonylpyrrolidine–2-carbonyl)amino)hexyl)azanium
Beyond the preview
Go deeper on methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate.